Skip to main content
. 2023 Mar 30;7:e2200463. doi: 10.1200/PO.22.00463

FIG A2.

FIG A2.

The therapy status of patients in the chemo-anti-PD1/PD-L1 group at data cutoff. At data cutoff, 36 patients in the chemo-anti-PD1/PD-L1 group were still under therapy. Among 32 patients who had discontinued therapy, 12 patients achieved pCR or NED and terminated therapy under the guidance of clinicians, while the others discontinued therapy for disease progression, adverse events, or willingness.